World News: 19:01 GMT Monday 16th April 2018. [Affimed N.V. via Globe Newswire via SPi World News]
Despite several marketed agents such as cetuximab and tyrosine kinase inhibitors there is a significant medical need for a novel approach to treat EGFR tumors by widening the therapeutic window and addressing current treatment resistance To meet the nee...
Globe Newswire: 19:01 GMT Monday 16th April 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.